Worldwide Trends on COVID-19 Research After the Declaration of COVID-19 Pandemic
NCT ID: NCT04460547
Last Updated: 2020-07-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2020-07-25
2020-09-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 Patients
NCT04502342
COVID-19 Disease Duration and GIT Manifestations. A New Disease Severity Classification. An Egyptian Experience
NCT04554979
Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19
NCT04359537
Efficacy of Mefloquine as Prophylaxis Against COVID-19: A Placebo-control, Randomized Clinical Trial
NCT04847661
Characteristics and Outcome of Coronavirus Disease 2019 (COVID-19) in Egypt
NCT04339322
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
AIMs \& Objectives of the Study This Observational Cross sectional study aims to explore the completed Researches in WHO-compliant registries to understand the trends of COVID-19 Research.
This study results can directly benefit the worldwide Academicians and Health Care Professionals to understand the ongoing COVID-19 Research trends.
Primary Outcomes of the Study To understand the geographical distribution of the interventional studies after 11th of March 2020.
To understand the geographical distribution of the Observational studies after 11th of March 2020.
To understand the monthly Research study completion rate as per geographic distribution of the Research.
Secondary Outcomes of the Study To understand the statistical correlation of the interventional studies Research with developed, developing and under developed countries.
To understand the statistical correlation of the observational studies Research with developed, developing and under developed countries.
To understand the statistical correlation of the Drug based interventional studies Research with developed, developing and under developed countries.
To understand the statistical correlation of the Diagnostic test based interventional studies Research with developed, developing and under developed countries.
To understand the statistical correlation of the Device based interventional studies Research with developed, developing and under developed countries.
Methodology WHO-compliant registries will be explored for completed COVID-19 Research articles.
Inclusion Criteria Interventional studies in the WHO-compliant registries database which are registered and completed after 11th of March 2020 until 15th of August 2020.
Observational studies in the WHO-compliant registries database which are registered and completed after 11th of March 2020 until 15th of August 2020.
Exclusion Criteria Interventional studies in the WHO-compliant registries database which are registered and completed before 11th March 2020.
Observational studies in the WHO-compliant registries database which are registered and completed before 11th March 2020.
The articles selected from the WHO-compliant registries database will be categorized as per following relevance:
Interventional Studies: Theses studies will be further categorized based on type of Intervention. Inteventional studies can be Drug, Diagnostic tests, Rehabilitation, Procedure, Device, Behavioral, Dietary supplement, Biological, Physiotherapy \& Others types of Interventional study.
Observational Studies: Prospective and Retrospective Observational studies.
The Studies will be mapped according to the Country where the Research is completed and the type of Research.
Type of Variables studied in this Study 6 Continuous variables are studied in this Study Number of Interventional Studies (Continuous variable) Number of Observational Studies (Continuous variable) Number of Drug based Interventional Study (Continuous variable) Number of Diagnostic test based interventional study (Continuous variable) Number of Device based interventional study (Continuous variable) Monthly Research study completion rate (Continuous variable)
8 Categorical variables will be studies in this study Interventional Study (Categorical variable) Observational Study (Categorical variable) Developed country (Categorical variable) Developing country (Categorical variable) Under developed country (Categorical variable) Drug based Interventional Study (Categorical variable) Diagnostic test based interventional study (Categorical variable) Device based interventional study (Categorical variable)
Statistical Analysis Data analysis will be carried out using SPSS 22.00 (Stata Corp, College Station, TX, USA). The Data obtained will be analysed for the normal distribution. If the data follows normal distribution curve, Pearson Correlation statistical test will be used to assess the Correlation of categorical and continuous variables. If the data does not follow normal distribution curve, Spearman Correlation or Chi square statistical test will be used to assess the Correlation of Categorical and continuous variables. The p-value (significance level) of the correlation will be determined. If the p-value is \<5%, then the correlation between variables analysed will be considered as significant.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Completed Interventional studies
Interventional studies in the WHO-compliant registries database which are registered and completed before 11th March 2020.
Convalescent Plasma Transfusion
Convalescent Plasma Transfusion to COVID-19 infected patients.
Hydroxychloroquine
Hydroxychloroquine administration to COVID-19 infected patients.
DAS181
DAS181 administration to COVID-19 infected patients.
Ivermectin
Ivermectin administration to COVID-19 infected patients.
Interferon Beta-1A
Interferon Beta-1A administration to COVID-19 infected patients.
Completed Observational studies
Observational studies in the WHO-compliant registries database which are registered and completed before 11th March 2020.
Convalescent Plasma Transfusion
Convalescent Plasma Transfusion to COVID-19 infected patients.
Hydroxychloroquine
Hydroxychloroquine administration to COVID-19 infected patients.
DAS181
DAS181 administration to COVID-19 infected patients.
Ivermectin
Ivermectin administration to COVID-19 infected patients.
Interferon Beta-1A
Interferon Beta-1A administration to COVID-19 infected patients.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Convalescent Plasma Transfusion
Convalescent Plasma Transfusion to COVID-19 infected patients.
Hydroxychloroquine
Hydroxychloroquine administration to COVID-19 infected patients.
DAS181
DAS181 administration to COVID-19 infected patients.
Ivermectin
Ivermectin administration to COVID-19 infected patients.
Interferon Beta-1A
Interferon Beta-1A administration to COVID-19 infected patients.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Observational studies in the WHO-compliant registries database which are registered and completed after 11th of March 2020 until 15th of August 2020.
Exclusion Criteria
Observational studies in the WHO-compliant registries database which are registered and completed before 11th March 2020.
1 Year
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Qassim University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Shiva Shankar Bugude
Assistant Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COAHS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.